Journal
EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING
Volume 20, Issue 10, Pages 1075-1093Publisher
OXFORD UNIV PRESS
DOI: 10.1093/ehjci/jez178
Keywords
dilated cardiomyopathy; prognosis; treatment; echocardiography; cardiac magnetic resonance; nuclear imaging
Funding
- Bristol National Institute of Health Research (NIHR) Biomedical Research Centre (BRC)
Ask authors/readers for more resources
Dilated cardiomyopathy (DCM) is defined by the presence of left ventricular or biventricular dilatation and systolic dysfunction in the absence of abnormal loading conditions or coronary artery disease sufficient to explain these changes. This is a heterogeneous disease frequently having a genetic background. Imaging is important for the diagnosis, the prognostic assessment and for guiding therapy. A multimodality imaging approach provides a comprehensive evaluation of all the issues related to this disease. The present document aims to provide recommendations for the use of multimodality imaging according to the clinical question. Selection of one or another imaging technique should be based on the clinical condition and context. Techniques are presented with the aim to underscore what is 'clinically relevant' and what are the tools that 'can be used'. There remain some gaps in evidence on the impact of multimodality imaging on the management and the treatment of DCM patients where ongoing research is important.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available